Topas Therapeutics GmbH

Topas Therapeutics GmbH is a company in Hamburg, Germany that has taken part in 2 EU-funded projects since 2020, receiving €409k in EU funding.

EU funding received€409k
EU projects2
As coordinator0
Running now0
First EU project2020
Latest project2021
CountryGermany
EU registration (PIC)946259639
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Topas Therapeutics GmbH's own share of each project, not the project's full budget.

  • Horizon 2020€409k · 2 projects

Projects

2 EU-funded projects, newest first. Each links to the official record.

  • PhoenixPartner

    Pharmaceutical Open Innovation Test Bed for Enabling Nano-pharmaceutical Innovative Products

    Horizon 2020 · 2021–2025 · Project on CORDIS ↗

    €409ktheir share
  • EDUC8Partner

    Early Stage Researchers EDUCational Program on Factor VIII Immunogenicity

    Horizon 2020 · 2020–2024 · Project on CORDIS ↗

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • entrepreneurship
  • immunology
  • nanomedicine
  • proteins

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime